ODT
Odonate Therapeutics, Inc. Common Stock
Delisted
ODT was delisted on the 14th of January, 2022.
94 hedge funds and large institutions have $721M invested in Odonate Therapeutics, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 40 increasing their positions, 23 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
31% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 16
6% more funds holding
Funds holding: 89 → 94 (+5)
Holders
94
Holding in Top 10
4
Calls
$3.03M
Puts
$2.18M
Top Buyers
| 1 | +$13.2M | |
| 2 | +$10.5M | |
| 3 | +$7.68M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$5.3M |
| 5 |
Two Sigma Advisers
New York
|
+$4.91M |
Top Sellers
| 1 | -$14.7M | |
| 2 | -$6.64M | |
| 3 | -$3.42M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$2.15M |
| 5 |
SCM
Sio Capital Management
New York
|
-$1.14M |